Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Acquisition Rewarding Patient Investors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Credit Suisse Upgrades Medicis (MRX) to Neutral
September 4, 2012 7:00 AM EDTCredit Suisse upgraded Medicis (NYSE: MRX) from Underperform to Neutral after the buyout of the company.
For an analyst ratings summary and ratings history on Medicis click here. For more ratings news on Medicis click here.
Shares of Medicis closed at $31.56 yesterday, with a 52 week range of $29.76-$40.10.... More
Valeant (VRX) to Acquire Medicis (MRX) to $44/Share; Deal Valued at $2.6B
September 4, 2012 6:29 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX: VRX) and Medicis Pharmaceutical Corporation (NYSE: MRX) entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Medicis for $44.00 per share in cash.
The transaction, which values Medicis' common stock at approximately $2.6 billion, was unanimously approved by the Boards of Directors of both... More
